Skip to main content

Published locations for Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer

User login

  • Reset your password
  • /content/adjuvant-abemaciclib-et-combo-shows-long-term-benefit-high-risk-early-breast-cancer
  • /fedprac/article/266044/breast-cancer/adjuvant-abemaciclib-et-combo-shows-long-term-benefit-high-risk
  • /oncologypractice/article/266044/breast-cancer/adjuvant-abemaciclib-et-combo-shows-long-term-benefit
  • /fedprac/avaho/article/266044/breast-cancer/adjuvant-abemaciclib-et-combo-shows-long-term-benefit
  • /hematology-oncology/article/266044/breast-cancer/adjuvant-abemaciclib-et-combo-shows-long-term
  • /breast-cancer-icymi/article/266044/breast-cancer/adjuvant-abemaciclib-et-combo-shows-long-term